Follow
Christopher Blair
Christopher Blair
University of Michigan Medical School Division of Infectious Diseases
Verified email at med.umich.edu
Title
Cited by
Cited by
Year
Neutrophil extracellular traps in COVID-19
Y Zuo, S Yalavarthi, H Shi, K Gockman, M Zuo, JA Madison, C Blair, ...
JCI insight 5 (11), 2020
16102020
Association between mRNA vaccination and COVID-19 hospitalization and disease severity
MW Tenforde, WH Self, K Adams, M Gaglani, AA Ginde, T McNeal, ...
Jama 326 (20), 2043-2054, 2021
6522021
Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study
AS Lauring, MW Tenforde, JD Chappell, M Gaglani, AA Ginde, T McNeal, ...
bmj 376, 2022
6002022
Comparative effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) vaccines in preventing COVID-19 hospitalizations among adults without immunocompromising …
WH Self
MMWR. Morbidity and mortality weekly report 70, 2021
5032021
Sustained effectiveness of Pfizer-BioNTech and Moderna vaccines against COVID-19 associated hospitalizations among adults—United States, March–July 2021
MW Tenforde
MMWR. Morbidity and mortality weekly report 70, 2021
2562021
Neutrophil calprotectin identifies severe pulmonary disease in COVID-19
H Shi, Y Zuo, S Yalavarthi, K Gockman, M Zuo, JA Madison, C Blair, ...
Journal of Leucocyte Biology 109 (1), 67-72, 2021
1432021
Temporal dynamics of SARS-CoV-2 mutation accumulation within and across infected hosts
AL Valesano, KE Rumfelt, DE Dimcheff, CN Blair, WJ Fitzsimmons, ...
PLoS pathogens 17 (4), e1009499, 2021
1072021
Effectiveness of a third dose of Pfizer-BioNTech and Moderna vaccines in preventing COVID-19 hospitalization among immunocompetent and immunocompromised adults—United States …
MW Tenforde
MMWR. Morbidity and mortality weekly report 71, 2022
1002022
Effectiveness of severe acute respiratory syndrome coronavirus 2 messenger RNA vaccines for preventing coronavirus disease 2019 hospitalizations in the United States
MW Tenforde, MM Patel, AA Ginde, DJ Douin, HK Talbot, JD Casey, ...
Clinical Infectious Diseases 74 (9), 1515-1524, 2022
922022
Vaccine effectiveness of primary series and booster doses against covid-19 associated hospital admissions in the United States: living test negative design study
K Adams, JP Rhoads, D Surie, M Gaglani, AA Ginde, T McNeal, HK Talbot, ...
Bmj 379, 2022
772022
SARS-CoV-2 Total and Subgenomic RNA Viral Load in Hospitalized Patients
DE Dimcheff, AL Valesano, KE Rumfelt, WJ Fitzsimmons, C Blair, ...
The Journal of Infectious Diseases, 2021
512021
High prevalence of extended-spectrum beta-lactamase CTX-M–producing Escherichia coli in small-scale poultry farming in rural Ecuador
HD Hedman, JNS Eisenberg, KA Vasco, CN Blair, G Trueba, VJ Berrocal, ...
The American journal of tropical medicine and hygiene 100 (2), 374, 2019
342019
SARS-CoV-2 genomic surveillance reveals little spread from a large university campus to the surrounding community
AL Valesano, WJ Fitzsimmons, CN Blair, RJ Woods, J Gilbert, D Rudnik, ...
Open Forum Infectious Diseases 8 (11), ofab518, 2021
232021
Ascertainment of vaccination status by self‐report versus source documentation: Impact on measuring COVID‐19 vaccine effectiveness
M Stephenson, SM Olson, WH Self, AA Ginde, NM Mohr, M Gaglani, ...
Influenza and other respiratory viruses 16 (6), 1101-1111, 2022
212022
Effectiveness of mRNA vaccines against COVID-19 hospitalization by age and chronic medical conditions burden among immunocompetent US adults, March-August 2021
NM Lewis, EA Naioti, WH Self, AA Ginde, DJ Douin, H Keipp Talbot, ...
The Journal of infectious diseases 225 (10), 1694-1700, 2022
192022
Protection of mRNA vaccines against hospitalized COVID-19 in adults over the first year following authorization in the United States
MW Tenforde, WH Self, Y Zhu, EA Naioti, M Gaglani, AA Ginde, K Jensen, ...
Clinical Infectious Diseases 76 (3), ciac381, 2023
82023
Effectiveness of the Ad26. COV2. S (Johnson & Johnson) COVID-19 vaccine for preventing COVID-19 hospitalizations and progression to high disease severity in the United States
NM Lewis, WH Self, M Gaglani, AA Ginde, DJ Douin, HK Talbot, JD Casey, ...
Clinical Infectious Diseases: An Official Publication of the Infectious …, 2022
22022
Effectiveness of mRNA Vaccines Against COVID-19 Hospitalization by Age and Chronic Medical Conditions Burden Among Immunocompetent US Adults, March-August 2021
IVY Network Collaborators
Journal of Infectious Diseases 225 (10), 1694-1700, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–18